quantisnow
FeedTopReportsPricing
⌘K
Live feed
08:42:41·41d
ANALYSTRating
Qiagen N.V. logo

Qiagen upgraded by Deutsche Bank with a new price target

QGEN· Qiagen N.V.
Health Care
Original source

Companies

  • QGEN
    Qiagen N.V.
    Health Care

Recent analyst ratings

  • Apr 14UpdateBarclays$44.00
  • Mar 13UpdateDeutsche Bank$54.00
  • Jan 22UpdateDeutsche Bank$54.00
  • Dec 11UpdateCitigroup$50.00
  • Jun 24UpdateBarclays$55.00
  • Apr 4UpdateRedburn Atlantic-

Related

  • PR7d
    QIAGEN to Showcase New Sample to Insight Solutions for Complex Oncology Applications at AACR 2026
  • PR9d
    QIAGEN Expands Into Bloodstream Infection Syndromic Testing With New Rapid QIAstat-Dx Panel
  • ANALYST9d
    Qiagen downgraded by Barclays with a new price target
  • PR34d
    Qiagen Announces Form 20-F Annual Report Filing for 2025 Results
  • SEC35d
    SEC Form 20-F filed by Qiagen N.V.
  • SEC35d
    SEC Form IRANNOTICE filed by Qiagen N.V.
  • PR35d
    QIAGEN Highlights Newly Published Data Supporting Efficacy of QuantiFERON for TB Prevention
  • PR44d
    QIAGEN Receives U.S. Clearance for Gastrointestinal Panels on Fully Automated QIAstat-Dx Rise Syndromic Testing System
quantisnow

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releasesAnalyst ratingsInsider tradingFDASECRSS feeds

Top lists

TrendingBy market capActive companiesAnalyst upgradesInsider purchasesFDA approvalsSEC filingsSectorsMarket reports

Company

AboutPricingPublish with usContact

Legal

Terms of usePrivacy policyCookie policy

© 2026 quantisnow.com · Democratizing insights since 2022